Notification of Transactions of Directors and Persons Discharging Managerial Responsibility
I give below details of changes in the interests of:
Persons Discharging Managerial Responsibility in the Ordinary shares of GlaxoSmithKline plc in respect of the under mentioned persons arising from the sale of Ordinary shares at a price of £11.33 per Ordinary share on 23 February 2009 to meet their tax liabilities following the vesting of a Share Value Plan award:
|
No. of Shares Awarded |
No. of Shares Sold |
No. of Shares Retained |
Mr S M Bicknell |
3,160 |
1,296 |
1,864 |
Mr E J Gray |
3,350 |
1,374 |
1,976 |
Mr D Learmouth |
3,160 |
1,296 |
1,864 |
Mr D S Redfern |
3,350 |
1,374 |
1,976 |
Ms C Thomas |
2,520 |
1,034 |
1,486 |
Persons Discharging Managerial Responsibility in the American Depositary Shares (ADSs) of GlaxoSmithKline plc in respect of the under mentioned person arising from the sale of ADSs at a price of $32.55 per ADS on 23 February 2009 to meet his tax liabilities following the vesting of a Share Value Plan award:
|
No. of ADSs Awarded |
No. of ADSs Sold |
No. of ADSs Retained |
Mr W C Louv |
1,480 |
496 |
984 |
The Company and Persons Discharging Managerial Responsibility were advised of these transactions on 24 February 2009.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
24 February 2009